Inter Pharma PCL Income Statement

Financials in millions THB. Fiscal year is January - December.

Millions THB. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Revenue	2,193	1,897	1,781	1,523	908.63
Other Revenue	20.57	14.62	17.54	11.12	12.35
Revenue	2,214	1,912	1,799	1,534	920.98
Revenue Growth (YoY)	15.80%	6.29%	17.23%	66.61%	106.07%
Cost of Revenue	1,293	1,188	1,122	905.42	507.85
Gross Profit	920.76	724.36	676.98	629.03	413.14
Selling, General & Admin	728.78	650.14	567.58	458.23	267.36
Operating Expenses	728.78	650.14	567.58	458.23	267.36
Operating Income	191.97	74.22	109.4	170.8	145.77
Interest Expense	-19.58	-19.85	-25.76	-23.34	-8.01
Earnings From Equity Investments	-1.23	-1.59	-2.27	-0.77	-0.08
EBT Excluding Unusual Items	171.17	52.78	81.37	146.69	137.68
Pretax Income	171.17	52.78	81.37	146.69	137.68
Income Tax Expense	35.1	16.16	22.47	19.41	27.2
Earnings From Continuing Operations	136.07	36.63	58.9	127.29	110.48
Minority Interest in Earnings	-13.69	0.02	-8.11	-8.4	-5.27
Net Income	122.38	36.65	50.79	118.88	105.22
Net Income to Common	122.38	36.65	50.79	118.88	105.22
Net Income Growth	233.93%	-27.84%	-57.28%	12.99%	100.27%
Shares Outstanding (Basic)	605	605	605	532	475
Shares Outstanding (Diluted)	605	605	605	532	475
Shares Change (YoY)	-	-	13.78%	11.97%	1.05%
EPS (Basic)	0.20	0.06	0.08	0.22	0.22
EPS (Diluted)	0.20	0.06	0.08	0.22	0.22
EPS Growth	233.93%	-27.84%	-62.45%	0.91%	98.19%
Free Cash Flow	167.33	-59.59	14.96	115.72	-265.73
Free Cash Flow Per Share	0.28	-0.10	0.03	0.22	-0.56
Dividend Per Share	0.073	-	0.021	0.111	-
Dividend Growth	-	-	-80.69%	-	-
Gross Margin	41.59%	37.89%	37.64%	40.99%	44.86%
Operating Margin	8.67%	3.88%	6.08%	11.13%	15.83%
Profit Margin	5.53%	1.92%	2.82%	7.75%	11.42%
Free Cash Flow Margin	7.56%	-3.12%	0.83%	7.54%	-28.85%
EBITDA	272.49	138.54	167.66	208.7	170.85
EBITDA Margin	12.31%	7.25%	9.32%	13.60%	18.55%
D&A For EBITDA	80.51	64.32	58.25	37.9	25.08
EBIT	191.97	74.22	109.4	170.8	145.77
EBIT Margin	8.67%	3.88%	6.08%	11.13%	15.83%
Effective Tax Rate	20.50%	30.61%	27.61%	13.23%	19.75%
Revenue as Reported	2,214	1,912	1,799	1,534	920.98
Advertising Expenses	31.27	93.14	70.61	31.91	41.13

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.